Skip to main content


Naloxone vs. Nalmefene: Understanding the Evidence


Stigma-Reducing Language

"Don't Label Us" Campaign 
Queen Anne’s County Department of Health's award-winning education and stigma-reducing campaign about MOUD

Conversation Starters for Patients and Their Doctors 
CDC released four new fact sheets to encourage patients and doctors to discuss pain management options and the potential risks of opioid medication. The four resources cover the important questions and information that patients and healthcare providers should cover when they talk about acute pain, chronic pain, prescription opioids, and reducing risk of opioid addiction.

How to talk with your patients about substance use disorders 
Talking with patients about potential substance misuse can be challenging. This overview and video from AMA demonstrates how one physician approaches this conversation during her addiction consultations with patients.

The Power of Perceptions & Understanding: Changing How We Deliver Treatment & Recovery Services 
This four-part webcast series from SAMHSA educates healthcare professionals about the importance of using approaches that are free of discriminatory attitudes and behaviors in treating individuals with substance use disorders (SUDs) and related conditions, as well as patients living their lives in recovery.

Language Guide 
A list of links to guides and resources on changing the language around substance use disorder recovery and treatment.

Addiction and Substance Use Disorders: Tips for Communicating without Stigma

Words Matter - Terms to Use and Avoid When Talking About Addiction 

Stigma as a fundamental hindrance to the United States opioid overdose crisis response 

Screening & Prevention Tools

Screening Tools and Prevention (NIDA) 
Provides links to evidence-based screening, assessment, and prevention tools and is organized by substance type, patient age, and administration method to help you find the right tool for your practice.

Screening, Brief Intervention, and Referral to Treatment (SBIRT) 
SBIRT is an approach to the delivery of early intervention and treatment to people with substance use disorders and those at risk of developing these disorders.

Addressing Alcohol Use Practice Manual (AAFP) 
This AAFP practice manual provides a systems-change approach for implementing alcohol SBI into your practice.

Appropriate Use of Drug Testing in Clinical Addiction Medicine (ASAM)
Guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.

  • Drug Testing Pocket Guide
    Download the full ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine in journal format.

Treatment Guidelines

Substance Use Disorders

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Focused Update 
which provides the latest information on evidence-based treatment of opioid use disorder (OUD) to guide clinicians in assessing, diagnosing, and treating OUD in the United States.

Best Practices and Barriers to Engaging People with Substance Use Disorders in Treatment 
This study used NCQA-accredited HEDIS data, which captures at least 75 percent of health plans, to identify high performing plans on the IET measure to help assess characteristics and interventions associated with better initiation and engagement of SUD treatment by plan members

Rural Prevention and Treatment of Substance Use Disorders Toolkit 
This toolkit from the Rural Health Information Hub provides evidence-based examples, promising models, program best practices, and resources that can be used by your organization to implement substance use disorder prevention and treatment programs.

Knoweledge Application Network (SAMHSA)
Review products used for technical assistance as well as publications and manuals for treatment protocols.

Substance Abuse Confidentiality Regulations 
Frequently Asked Questions (FAQs) regarding the Substance Abuse Confidentiality Regulations.

Alcohol Use Disorder

Identification of and Treatment for Unhealthy Alcohol Use in Primary Care Settings 
Ways in which family physicians can implement this screening recommendation and then intervene when a patient has a positive screen.

Pharmacotherapy for Alcohol Use Disorder 
This PCSS module reviews and compares pharmacological treatment options for individuals with AUD, including acamprosate, disulfiram, and naltrexone (oral and long-acting intramuscular formulations

ASAM Clinical Practice Guideline on Alcohol Withdrawal Management 
This clinical guideline provides the latest information to provide guidance on the identification and management of alcohol withdrawal in patients with varying degrees of syndrome severity.

The NIAAA Alcohol Treatment Navigator® 
Today there are more treatment choices than you may expect for your patients or clients with alcohol use disorder (AUD). The NIAAA Alcohol Treatment Navigator will help you find evidence-based care for your patients or clients.

Implementing Screening and Treatment of Unhealthy Alcohol Use During COVID-19 
AHRQ is responding to the rise in unhealthy alcohol use by supporting the implementation of evidence around unhealthy alcohol use screening and treatment.

Advances in the science and treatment of alcohol use disorder 


HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics 
The HHS Guide provides advice to clinicians who are contemplating or initiating a change in opioid dosage.

Before It's Too Late (BHA/MDH) 
The Maryland statewide effort to bring awareness to the rapid escalation of the heroin, opioid, and fentanyl crisis in Maryland–and to mobilize all available resources for effective prevention, treatment, and recovery before it’s too late.

AMA Opioid Task Force Recommendations for Physicians 
Actions physicians can take to demonstrate leadership and help end the nation’s opioid epidemic.

Opioid Overdose Prevention Toolkit (SAMHSA) 
This toolkit offers strategies to health care providers, communities, and local governments for developing practices and policies to help prevent opioid-related overdoses and deaths.

Prevención de la Sobredosis de Opioides Manual de Instrucción (SAMHSA)
Equipa a los proveedores de atención médica, las comunidades y los gobiernos locales con materiales para desarrollar prácticas y políticas para ayudar a prevenir las sobredosis y las muertes relacionadas con los opioides.

Medications for Opioid Use Disorder

Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings 
Guidance and step-by-step tactics on implementing opioid use disorder treatment using buprenorphine.

Medication Treatment for Opiod Use Disorder in the Primary Care Setting (NIDA)
Getting started: Preparing your practice and treating patients.

Medication Assisted Treatment for Opioid Addiction: Pocket Guide Physicians (SAMHSA)
Condensed, downloadable guide on Medication Assisted Treatment for Opioid Addiction.

MATx Mobile App for MAT Providers
This free app supports practitioners who currently provide medication-assisted treatment (MAT), as well as those who plan to do so in the future.

TIP 63: Medications for Opioid Use Disorder (SAMHSA)
Medications for Opioid Use Disorder for Healthcare and Addiction Professionals, Policymakers, Patients, and Families

Buprenorphine Master Class: Managing Opioid Use Disorder for the Generalist 
Treating people with Opioid Use Disorder can be the most rewarding part of your practice! Get comfortable with counseling and pharmacotherapy for OUD with tips from MACS Consultant, Dr. Michael Fingerhood on the Curbsiders, a CME podcast accredited by ACP.

Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures (Pain Physician Journal)
The present investigation aims to review the literature and provide recommendations when encountering a patient on buprenorphine therapy who is scheduled for a surgical or interventional pain procedure.

Sublingual & Transmucosal Buprenorphine for OUD: Review and Update (SAMHSA)
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Transfer from Methadone to Buprenorphine Guidance (PCSS)

Buprenorphine Home Induction App (Yale) 
An informative mobile application that guides patients on how to conduct Buprenorphine induction using a series of questions that the patient is asked in the mobile application.

Patient wants to stop taking buprenorphine
Dr. Edwin Salsitz, a Providers Clinical Support System Clinical (PCSS) expert, speaks to a patient who has been on buprenorphine and has done well and now wants to taper off buprenorphine.

Stimulant Use Disorder

Treatment of Stimulant Use Disorders 
This guide from SAMHSA supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.

Pain Management

UPDATE: CDC Guideline for Prescribing Opioids for Chronic Pain
CDC Guide to provide recommendations for the prescribing of opioid pain medication for patients 18 and older in primary care settings.

Maryland State Medical Board Opioid Prescribing Guidelines 
In light of the opioid epidemic, the Maryland State Board of Physicians has adopted the following guidance for Maryland physicians and physician assistants to consider when determining whether and how to prescribe opioids.

SCOPE of Pain
Find information, resources and tools about safe and competent opioid prescribing for patients with chronic pain.

SCOPE of Pain Trainer's Toolkit
Interactive Trainer's Toolkit that you can use to train all the clinicians in your facility, practice or health system on all facets of opioid prescribing. 

AAFP Chronic Pain Management Toolkit
Designed to help family physicians identify gaps in practice flow, standardize evaluation and treatment of chronic pain patients, and facilitate conversations surrounding pain and treatment goals, as well as identify and mitigate risk.

Pain Management and Opioids Resources (ASAM)
Link to materials available on pain management and opioid related topics as well as materials from the Pain Management and Opioids: Balancing Risks and Benefits course.

When to refer a patient to a pain specialist (AAPM)
Document to assist primary care providers in providing their patients the best of chronic pain care.

Health Equity

Advancing Racial Equity in the Substance Use Field (Opioid Response Network) 
The ORN offers workshops and training, technical assistance, and ongoing consultation and support for all your diversity and racial equity capacity building efforts. This includes requests related to diversity, equity, and inclusion (DEI) topics, such as addressing racial disparities and the intersection of race with social determinants of health, LGBTQ+ health, gender, gender diversity, and health disparities.

Incorporating a Race Equity Framework into Opioid Use Disorder Treatment 
A Chapter in Consistently employing a racial equity framework that explicitly inserts race and power into the decision-making process and promotes active engagement of stakeholders is often a key component missing in the decision-making process impacting racial/ethnic minorities with OUD.

Building Health Equity & Inclusion (Addiction Technology Transfer Center)
Health equity is the right to access quality health care for all populations regardless of the individual’s race, ethnicity, gender, socioeconomic status, sexual orientation, or geographical location. This includes access to prevention, treatment, and recovery services for mental and substance use disorders. These resources from ATTC help behavioral health providers ensure they are building practices and providing services that are equitable for all.

Building Health Equity & Inclusion (Prevention Technology Transfer Center)
This resource list was developed by the PTTC Culturally & Linguistically Appropriate Practices Work Group, and represents a compilation of resources produced by the PTTC Network to help individuals understand the impact of culture and identity in prevention efforts.

Behavioral Health Equity (SAMHSA)
The Office of Behavioral Health Equity coordinates SAMHSA’s efforts to reduce disparities in mental and/or substance use disorders across populations. Its work is organized around key strategies, including data, policy, and quality practice and workforce development.

Improving Cultural Competence 
This guide from SAMHSA helps professional care providers and administrators understand the role of culture in the delivery of mental health and substance use services. It describes cultural competence and discusses racial, ethnic, and cultural considerations. 

Behavioral Health Implementation Guide for the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care 
The Behavioral Health Guide is a companion document to the Blueprint for Advancing and Sustaining CLAS Policy and Practice. Together these documents provide concrete, feasible implementation strategies for the health and behavioral healthcare community to improve the provision of services to all individuals, regardless of race, ethnicity, language, socioeconomic status, and other cultural characteristics. 

Advancing Racial Justice in Addiction Medicine (ASAM) 
These statements are part of ASAM’s effort to recognize, understand, and then counteract the adverse effects of America’s historical, pervasive, and continuing systemic racism, specifically with respect to addiction prevention, early intervention, diagnosis, treatment, and recovery. The goal of this series is to increase structural competency among addiction medicine professionals, public health authorities, policymakers and others with societal influence or authority. 

A Physician’s Practical Guide to Culturally Competent Care - for physicians, nurse practitioners, and physician assistants
As healthcare disparities among cultural minority groups persist in our country, culturally and linguistically appropriate services (CLAS) are increasingly recognized as an important strategy for improving quality of care to diverse populations. This e-learning program from U.S. Department of Health & Human Services' Think Cultural Health Program will equip you with the knowledge, skills, and awareness to best serve all patients, regardless of cultural or linguistic background. 

Primary Care’s role in Achieving Health Equity: A guidebook to the Health Equity Curricular Toolkit 
The Health Equity Curricular Toolkit was championed by the Health Equity Team of Family Medicine for America’s Health and inspired by the Starfield II Health Equity Summit. This toolkit provides a structured curricular tool to facilitate exploration of some of the most pressing questions around social determinants of health, vulnerable populations, and economics and policy. The toolkit also provides resources to promote skill-building to confront drivers of persistent and pervasive inequities.

Culturally Competent limited English proficiency (LEP) and Low-literacy Services 
Entities that receive federal funding must take reasonable steps to ensure access to services for people with limited English proficiency (LEP).

Virtual training


TED Talks 

  • The problem with race-based medicine- Global scholar, University of Pennsylvania civil rights sociologist, and law professor Dorothy Roberts exposes the myths of race-based medicine. 
  • Allegories on race and racism- Camara Jones, MD, MPH 
  • How racism makes us sick - Sociologist David R. Williams challenges us to tackle the striking levels of early death and poor health that are due to the color of one’s skin. David is the Norman Professor of Public Health at Harvard’s T. H. Chan School of Public Health and Professor of African and African American Studies and of Sociology at Harvard University. 


Racial/Ethnic Groups 

Asian American, Native Hawaiian, and Pacific Islander

Black & African American


Native & Indigenous


Provider Substance Use Tools & Resources: Women 

Women and Opioid Use: The Missing Link in Prevention, Treatment and Recovery 

Caring for Women with Opioid Use Disorder: A Toolkit for Organization Leaders and Providers 
This HRSA toolkit provides resources and information to bolster care coordination services for women with opioid use disorder.

Substance Abuse Treatment: Addressing the Specific Needs of Women
This guide from SAMHSA assists providers in offering treatment to women living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of initial use and specific treatment issues and strategies.

White Paper: Opioid Use, Misuse, and Overdose in Women 
Developed to serve as a starting point for a September 2016 national meeting hosted by the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) to examine prevention, treatment, and recovery issues for women who misuse, have use disorders, and/or overdose on opioids. 

Pregnancy & Parenting 

Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
This Clinical Guide from SAMHSA provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants.

Healthy Pregnancy Healthy Baby Fact Sheets
This series of four fact sheets from SAMHSA emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy.

State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder
The National Academy for State Health Policy (NASHP) interviewed state Medicaid, behavioral health, and public health officials from Colorado, Pennsylvania, and Texas to learn about their unique interagency approaches to treating and supporting pregnant and parenting women with substance use disorder (SUD).

In-Depth Technical Assistance: Infants with Prenatal Substance Exposure 
This brief summarizes the accomplishments, key findings, and conclusions that emerged from three In-Depth Technical Assistance (IDTA) Infants with Prenatal Substance Exposure (IPSE) sites. 


Integrating Addiction Care and Gender Affirming Services for Transgender and Gender-Diverse Patients: A Case-Based Workshop (PowerPoint presentation download)

A Provider’s Introduction to Substance Abuse Treatment for Lesbian, Gay, Bisexual, and Transgender Individuals

Webinar: SBIRT with LGBT Patients: Identifying and Addressing Unhealthy Substance Use in Primary Care Settings

Additional Resources from SAMHSA
Resources on the LGBTQ+ population include national survey reports, agency and federal initiatives, and related behavioral health resources. 

Older Adults 

Substance Use Treatment for Older Adults 
Older adults age 50 and over with substance use disorders need treatment services that are sensitive to age-related or generational issues.

A Day in the Life of Older Adults: Substance Use Facts 

Linking Older Adults With Medication, Alcohol, and Mental Health Resources 

People in the Criminal Justice System 

Guidelines for Successful Transition of People with Mental or Substance Use Disorders from Jail and Prison
Provides examples of the implementation of successful strategies for transitioning people with mental or substance use disorders from institutional correctional settings into the community.

Drug Court Resources
Webinars and pocket guides for providing addiction treatment in drug court settings.

Individuals in the Criminal Justice System - ASAM eLearning Courses

Unhoused People

Adapting Your Practice:Recommendations for the Care of Homeless Patients with Opioid Use Disorders 
The purpose of this document is to educate clinicians, other direct service providers, and program administrators about optimal care for people with opioid use disorders who are homeless or marginally housed, addressing clinical and programmatic issues. 

Treatment for Individuals Experiencing Homelessness (TIEH) 
SAMHSA's Treatment for Individuals Experiencing Homelessness (TIEH) program expands access to mental and substance use disorders treatment for people experiencing homelessness along with a serious mental illness, serious emotional disturbance, or co-occurring disorders.

Treating Opioid Addiction in Homeless Populations: Challenges and Opportunities Providing Medication Assisted Treatment
This webinar identifies challenges to treating opioid addiction with Medication Assisted Treatment (Buprenorphine) in a health center environment, and discusses provider practices to overcome these challenges to promote access and recovery.

Strategies to Address the Intersection of the Opioid Crisis and Homelessness
This document identifies strategies that communities, providers, and policymakers can use to address the intersection of homelessness and the opioid crisis and highlights resources developed by federal and national partners to support such efforts.

Adapting Your Practice: Recommendations for the Care of Homeless Patients with Opioid Use Disorders

People with Cognitive & Physical Disabilities

Mental and Substance Use Disorder Treatment for People With Physical and Cognitive Disabilities 
This SAMHSA Advisory highlights how mental and substance use disorder (SUD) treatment programs can better serve people with physical and cognitive disabilities and SUDs and/or serious mental illness (SMI).



Comparing Substance Use and School-Based Stressors Among Black and Latinx Transgender Youth and Peers With Shared Minoritized Identities - Journal of Adolescent Health

Substance Use and Suicide Risk Among LGBTQ Youth - The Trevor Project

Changes in young adult substance use during COVID-19 as a function of ACEs, depression, prior substance use and resilience - Substance Abuse Journal

Adolescent substance use: Challenges and opportunities related to COVID-19 - Journal of Substance Abuse

What Does Adolescent Substance Use Look Like During the COVID-19 Pandemic? Examining Changes in Frequency, Social Contexts, and Pandemic-Related Predictors - Journal of Adolescent Health

As 2020 Closes, Many Questions Remain about Youth Substance Use Trends - NIDA

Buprenorphine treatment for adolescents and young adults with opioid use disorders: a narrative review - Journal of Addiction Medicine (MACS Consultant and Child / Addiction Psychiatrist, Dr. Marc Fishman, is an author)

Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults - JAMA Pediatrics

Suspected Nonfatal Drug-Related Overdoses Among Youth in the US: 2016–2019 - Pediatrics

Treating Youth’s Substance Use Disorder Using Telehealth: Clear Benefits, New Challenges - BMC

Conceptual framework for telehealth strategies to increase family involvement in treatment and recovery for youth opioid use disorder - Journal of Marital Therapy


CRAFFT substance use screening tool for adolescents aged 12-21 

Youth Substance Use Prevention, Treatment, and Recovery Resource Guide 

Getting Candid: Resources for providers


Youth and Substances: What’s a Primary Care Provider to Do?
Presenter: Marc Fishman, MD 
Date: September 25, 2020 
Youth and Substances slides
View on Webex

Treatment of Opioid Use Disorders in Youth
Presenter: Marc Fishman, MD 
Date: December 18, 2020 
Treatment of OUD in Youth slides
View on Webex

Harm Reduction

HIV/AIDS and Substance Use

Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders 
This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV.

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America 
This guidance from an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates previous 2013 primary care guidelines.

AIDS Education & Training Center 
Maryland education opportinities for providers from the Institute of Human Virology

HIV and Substance Use in the United States 
Information and resources from the CDC.

The Connection Between Substance Use and HIV 
Research report from NIDA.

Substance Use and HIV Risk 
HIV Prevention: Reducing Risk from Alcohol & Drug Use from

Syringe Services Programs (SSPs) 

Addressing Unhealthy Alcohol Use and the HIV Pre-exposure Prophylaxis Care Continuum in Primary Care: A Scoping Review

Local Data: Maryland

Center for HIV Prevention and Health Services

Supporting Families Impacted by Substance Use

Children and Families Affected by Parental Substance Use Disorders (NCSACW)
Resources that providers and communities can use to better serve families in child welfare affected substance use disorders. 

Maryland Substance Exposed Newborn Tool Kit 
The purpose of the toolkit is to educate the public, including, community service providers, local agencies, and health professionals, as to best practices for supporting substance exposed newborns and families impacted by substance use.

HHS Announces a Standard Clinical Definition for Opioid Withdrawal in Infants (For Immediate Release: 
Major step towards improving standards of care for infants prenatally exposed to opioids, part of the HHS Overdose Prevention Strategy

Steps you can take to decrease the impact of parental or household substance use 
Information sheet from MACS Consultant, Marc Fishman, MD

Parental Addiction Resources for Providers (Sesame Street)
Resources to help children and families grow and heal from the impact of parental addiction
Call us at 1-855-337-MACS to request a copy of the Parental Addiction book for your office.

SUD and Parental Addiction Webinars for Providers 
Sesame Street in Communities has developed a webinar series focused on substance use disorder and parental addiction to help providers support children and families.

The Role of Primary Care Providers in Decreasing Impact of Parental Addiction (National Association for Children of Addiction)
Family practitioners and others can act as important advocates for appropriate community and school-based prevention approaches and in educating patients and parent, ensuring that local programs are culturally relevant and appropriate for the various communities and populations they serve.

Suicide Prevention

Substance Use and Suicide: A Nexus Requiring a Public Health Approach  
SAMHSA's In Brief summarizes the relationship between substance use and suicide and provides state and tribal prevention professionals with information on the scope of the problem, an understanding of traditional barriers to collaboration and current programming, and ways to work together on substance misuse and suicide prevention strategies.

Risk Factors for Suicide among People with Chronic Pain 
Current evidence suggests that people who experience chronic pain are at increased risk for a number of adverse health outcomes, including opioid overdose and suicide.

Screening Tools for Suicide Risk, and Mental and Substance Use Disorders 
Provides links to a variety of screening tools on SAMHSA's website to identify trauma, suicide, substance use disorders, and other mental disorders.

Suicide Prevention Resource Database 
An extensive, searchable resource (e.g., articles, tools, fact sheets, reports) and program database developed by SPRC and other suicide prevention organizations and experts.

AFSP Maryland 

Substance Use Consultation Warmlines for Providers Practicing in Other States

National (United Stated)

National Substance Use Warmline 

District of Columbia

District Addiction Consultation Service (DACS) 
866-337-DACS (3227)


California Substance Use Line


University of Wisconsin Addiction Consultation Provider Hotline 


The Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) 
1-833-PAIN-SUD (1-833-724-6783)


Medication Assisted Treatment Recovery Initiative for Arkansas Rural Communities (MATRIARC) 


Michigan Opioid Collaborative (MOC) 

Know of a United States substance use consultation line for providers that isn't listed?

Let us know! Email 

Additional Resources

Behavioral Health Administration (BHA), Maryland Department of Health 
Learn more about how Maryland is combatting the heroin and opioid crisis.

Substance Abuse and Mental Health Services Administration (SAMHSA)
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

American Society of Addiction Medicine (ASAM)
ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

Providers Clinical Support System (PCSS)
These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.

National Institute on Alcohol Abuse and Alcoholism Clinician (NIAAA) Resources
Resources for clinicians, physicians, social workers, and other healthcare professionals.

National Institutes on Drug Abuse Clinician Resources (NIDA)
Science-based resources to health professionals on the causes and consequences of drug use and addiction, and advances in pain management.

U.S. Department of Health & Human Services (HHS) - National Opioid Crisis
Help, Resources, and Information on combating the national opioid epidemic.

Opioid Cloud Library 
A searchable library of curated, evidence-based resources on opioids and the opioid crisis.

Safe medication disposal 
Talk to your patients about the most appropriate way to dispose of expired, unwanted and unused medications.

The Maryland Department of Health (MDH) has made access to patient controlled dangerous substance (CDS) prescription information collected by the PDMP available at no-cost to physicians, nurse practitioners, pharmacists, and others who provide medical care to an individual with whom they have an existing treatment relationship. Providers can now register with CRISP​​ to get access to PDMP data to support patient care. See the Clinical Resources​ section for information on educational and training resources designed to assist providers with safe and effective use of CDS prescription drugs in patient care.

Learn more about the PDMP on the MDH website

The Maryland Addiction Consultation Service is administered by the University of Maryland School of Medicine and funded by the Maryland Department of Health, Behavioral Health Administration.